AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

143.06

+0.05

(+0.03%)

At close: 04:03PM EDT

143.50

+0.44

(+0.31%)

After hours:

07:57PM EDT

Loading interactive chart…

Motley Fool
3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right Now
A little-known group of Buffett stocks includes three members of dividend royalty with solid growth prospects.
Simply Wall St.
AbbVie Inc.'s (NYSE:ABBV) Business Is Trailing The Market But Its Shares Aren't
With a price-to-earnings (or "P/E") ratio of 20.1x AbbVie Inc. ( NYSE:ABBV ) may be sending bearish signals at the...
Motley Fool
Is AbbVie a Buy?
Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. AbbVie last reported its earnings in July. Humira remains key to AbbVie's business for now, generating $5.4 billion this past quarter, nearly three times the $1.8 billion Skyrizi and Rinvoq generated.